Collection: Cervical Cancer Awareness Month

In honor of Cervical Cancer Awareness Month this January, the cancer editors at Nature Communications have curated a collection of papers covering topics such as human papillomavirus, cervical tumor growth, risk factors and more.

Published in Cancer

Collection: Cervical Cancer Awareness Month
Like

Share this post

Choose a social network to share with, or copy the URL to share elsewhere

This is a representation of how your post may appear on social media. The actual post will vary between social networks

Cervical cancer is the fourth most common cancer for women worldwide. Almost all cases of cervical cancer are associated with human papilloma virus (HPV) infection. While the use of the Pap smear as a screening tool has helped to decrease the mortality rates, cervical cancer incidence and mortality remain significantly higher in low-income countries. As promising therapeutic options, three immunotherapy vaccines were recently approved by the FDA to prevent HPV infection and since their introduction the number of new cases of cervical cancer has dropped significantly.

With this collection of Nature Communications research in the field, we want to increase awareness of the disease among women, highlighting the importance of a wider vaccine coverage and screening to eradicate cervical cancer worldwide.

Browse the collection >>



Featured image: Sebastian Condrea/Getty

Please sign in or register for FREE

If you are a registered user on Research Communities by Springer Nature, please sign in

Follow the Topic

Cancer Biology
Life Sciences > Biological Sciences > Cancer Biology

Related Collections

With Collections, you can get published faster and increase your visibility.

Women's Health

A selection of recent articles that highlight issues relevant to the treatment of neurological and psychiatric disorders in women.

Publishing Model: Hybrid

Deadline: Ongoing

Tumor Microenvironment Crosstalk and Therapeutic Implications

With this cross-journal Collection, the editors at Nature Immunology, Nature Communications, Communications Medicine and Scientific Reports invite manuscripts that highlight cutting-edge research on TME crosstalk and its therapeutic implications. Topics of interest include immune modulation and checkpoint pathways, cancer-associated fibroblasts and stromal remodeling, angiogenesis and vascular normalization, metabolic reprogramming within the TME, and the role of microbiota in tumor-immune dynamics. We also welcome studies on novel therapeutic approaches that exploit TME vulnerabilities to advance cancer treatment.

Publishing Model: Hybrid

Deadline: Nov 02, 2026